Device
NMP
NMP is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed375%
enrolling_by_invitation125%
Recent Activity
0 active trials
Showing 4 of 4
enrolling_by_invitation
INDUCE: A Prospective 2-Year Spine Registry
NCT06971835
completednot_applicable
Frequency Parameter Used to Apply Ultrasound-guided Neuromodulation Percutaneous
NCT05106920
completednot_applicable
Ultrasound-guided Neuromodulation Percutaneous
NCT04590443
completednot_applicable
Ultrasound-guided Neuromodulation Percutaneous in Lower Back Pain
NCT04347265
Clinical Trials (4)
Showing 4 of 4 trials
NCT06971835
INDUCE: A Prospective 2-Year Spine Registry
NCT05106920Not Applicable
Frequency Parameter Used to Apply Ultrasound-guided Neuromodulation Percutaneous
NCT04590443Not Applicable
Ultrasound-guided Neuromodulation Percutaneous
NCT04347265Not Applicable
Ultrasound-guided Neuromodulation Percutaneous in Lower Back Pain
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4